Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Market Cap	6.77B
Revenue (ttm)	3.18B
Net Income (ttm)	389.08M
Shares Out	1.50B
EPS (ttm)	0.26
PE Ratio	17.45
Forward PE	9.50
Dividend	0.07 (1.49%)
Ex-Dividend Date	n/a

Volume	1,961,632
Average Volume	9,415,516
Open	4.500
Previous Close	4.500
Day's Range	4.460 - 4.520
52-Week Range	2.000 - 4.880
Beta	0.17
RSI	47.47
Earnings Date	May 13, 2025

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: RMDA

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.